Zhejiang Silicon Paradise Asset Management Group
VC Fund
Hangzhou, China
Zhejiang Silicon Paradise Asset Management Group is a private equity fund manager that focuses on equity investment in the smart technology, advanced manufacturing, and healthcare industries.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Zhejiang Silicon Paradise Asset Management Group invests in
Stages Zhejiang Silicon Paradise Asset Management Group invests in
Countries Zhejiang Silicon Paradise Asset Management Group invests in
Investment Focus
Industry
- Medical 2 (33%)
- Health Care 2 (33%)
- Medical Device 2 (33%)
- Biopharma 1 (17%)
- Enterprise 1 (17%)
Stage
- Series A 2 (33%)
- Series B 2 (33%)
- Seed 1 (17%)
- Series D 1 (17%)
Country
- China 4 (67%)
- United States 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xinzeyuan Medical
|
Xinzeyuan Medical is a manufacturer of key precision components and medical endoscope consumables. | $14.3M / Series B / Jul 08, 2024 | |
MetaLenX
|
MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses. | $13.7M / Series A / Oct 10, 2023 | |
Blue Wave
|
Blue Wave is a producer of Industrial IoT and Internet of Vehicles chips. | $13.7M / Seed / Sep 12, 2023 | |
remd
|
remd is a forward-thinking developer of irreversible electroporation technology, focusing on the research, development, production, and sale of the third type of medical equipment for tumour treatment, with high-frequency irreversible electroporation as its core technology. | $14.6M / Series A / Feb 17, 2023 | |
Denovo Biopharma
|
Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. The core technology is the industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stageclinical drugs that have completed trials with unsatisfactory efficacy. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in a targeted patient population to achieve significant efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in many therapeutic areas, such as oncology, metabolic, cardiology, immunology and neurology. | $42.5M / Series D / Dec 10, 2020 | |
ZStack
|
ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries. | $33.2M / Series B / Aug 19, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Zhejiang Silicon Paradise Asset Management Group invest in?
Zhejiang Silicon Paradise Asset Management Group invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Zhejiang Silicon Paradise Asset Management Group last invest?
The most recent investment recorded for Zhejiang Silicon Paradise Asset Management Group closed in Jul 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
